Jemal A, Siegal R, Ward R, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin. 2008, 58: 71-96. 10.3322/CA.2007.0010.
Article
PubMed
Google Scholar
Seiwert TY, Salama JK, Vokes EE: The chemoradiation paradigm in head and neck cancer. Nat Clin Pract Oncol. 2007, 4: 156-171. 10.1038/ncponc0750.
Article
CAS
PubMed
Google Scholar
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006, 354: 567-578. 10.1056/NEJMoa053422.
Article
CAS
PubMed
Google Scholar
Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G: PET/CT for the staging and follow-up of patients with malignancies. Eur J Radiol. 2009, 70: 382-92. 10.1016/j.ejrad.2009.03.051.
Article
CAS
PubMed
Google Scholar
Zanation AM, Sutton DK, Couch ME, Weissler MC, Shockley WW, Shores CG: Use, Accuracy, and Implications for Patient Management of [18F]-2-Fluorodeoxyglucose-Positron Emission/Computerized Tomography for Head and Neck Tumors. Laryngoscope. 2005, 115: 1186-1190. 10.1097/01.MLG.0000163763.89647.9F.
Article
PubMed
Google Scholar
Wax MK, Myers LL, Gabalski EC, Husain S, Gona JM, Nabi H: Positron Emission Tomography in the Evaluation of Synchronous Lung Lesions in Patients With Untreated Head and Neck Cancer Arch Otolaryngol Head Neck Surg. 2002, 128: 703-707.
Google Scholar
Kim SY, Roh JL, Yeo NK: Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Ann Oncol. 2007, 18: 1698-703. 10.1093/annonc/mdm270.
Article
CAS
PubMed
Google Scholar
Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Lin KJ, Lin WJ, Fu YK, Lin CY: The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med. 2005, 46: 405-10.
PubMed
Google Scholar
Murakami R, Uozumi H, Hirai T, Nishimura R, Shiraishi S, Ota K, Murakami D, Tomiguchi S, Oya N, Katsuragawa S, Yamashita Y: Impact of FDGPET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2007, 68: 377-382.
Article
PubMed
Google Scholar
Adams S, Baum RP, Stuckensen T, Bitter K, Hör G: Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998, 25: 1255-1260. 10.1007/s002590050293.
Article
CAS
PubMed
Google Scholar
Ng SH, Yen TC, Liao CT: 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: A prospective study of 124 patients with histologic correlation. J Nucl Med. 2005, 46: 1136-1143.
PubMed
Google Scholar
Hannah A, Scott AM, Tochon-Danguy H, Chan JG, Akhurst T, Berlangieri S, Price D, Smith GJ, Schelleman T, McKay WJ, Sizeland A: Evaluation of18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg. 2002, 236: 208-217. 10.1097/00000658-200208000-00009.
Article
PubMed Central
PubMed
Google Scholar
Ng SH, Yen TC, Chang JT, Chan JG, Akhurst T, Berlangieri S, Price D, Smith GJ, Schelleman T, McKay WJ, Sizeland A: Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol. 2006, 24: 4371-6. 10.1200/JCO.2006.05.7349.
Article
PubMed
Google Scholar
Civantos FJ, Gomez C, Duque C, Pedroso F, Goodwin WJ, Weed DT, Arnold D, Moffat F: Sentinel node biopsy in oral cavity cancer: Correlation with PET scan and immunohistochemistry. Head Neck. 2003, 25: 1-9. 10.1002/hed.10213.
Article
PubMed
Google Scholar
Hyde NC, Prvulovich E, Newman L, Waddington WA, Visvikis D, Ell P: A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: The role of sentinel node biopsy and positron emission tomography. Oral Oncol. 2003, 39: 350-360. 10.1016/S1368-8375(02)00121-5.
Article
CAS
PubMed
Google Scholar
Schwartz DL, Ford E, Rajendran J, Yueh B, Coltrera MD, Virgin J, Anzai Y, Haynor D, Lewellyn B, Mattes D, Meyer J, Phillips M, Leblanc M, Kinahan P, Krohn K, Eary J, Laramore GE: FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005, 61: 129-136.
Article
PubMed
Google Scholar
Stoeckli SJ, Steinert H, Pfaltz M, Schmid S: Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck. 2002, 24: 345-349. 10.1002/hed.10057.
Article
PubMed
Google Scholar
Fleming AJ, Smith SP, Saul CM: Impact of 18-F-2-Fluorodeozyglucose-positron emission tomography/computed tomography on previously untreated head and necak cancer patients. Laryngoscope. 2007, 117: 1173-79. 10.1097/MLG.0b013e31805d017b.
Article
PubMed
Google Scholar
Schwartz Dl, Ragendran J, Yueh B, Coltrera MD, Leblanc M, Eary J, Krohn K: FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg. 2004, 130: 1361-7. 10.1001/archotol.130.12.1361.
Article
PubMed
Google Scholar
Brun E, Kjellen E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, Perfekt R, Wennerberg J, Strand SE: FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck. 2002, 24: 127-135. 10.1002/hed.10037.
Article
PubMed
Google Scholar
Minn H, Lapela M, Klemi PJ, Grénman R, Leskinen S, Lindholm P, Bergman J, Eronen E, Haaparanta M, Joensuu H: Prediction of survival with fluorine-18-fluorodeoxyglucose and PET in head and neck cancer. J Nucl Med. 1997, 38: 1907-1911.
CAS
PubMed
Google Scholar
Halfpenny W, Hain SF, Biassoni L, Maisey MN, Sherman JA, McGurk M: FDG-PET: a possible prognostic factor in head and neck cancer. Br J Cancer. 2002, 86: 512-516. 10.1038/sj.bjc.6600114.
Article
PubMed Central
CAS
PubMed
Google Scholar
Roh JL, Pae KH, Choi SH, Kim JS, Lee S, Kim SB, Nam SY, Kim SY: 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx. Eur J Surg Oncol. 2007, 33: 790-5.
Article
PubMed
Google Scholar
Kim SY, Roh JL, Kim MR, Kim JS, Choi SH, Nam SY, Lee SW, Kim SB: Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx. J Nucl Med. 2007, 48: 752-7. 10.2967/jnumed.107.039610.
Article
PubMed
Google Scholar
Allal AS, Slosman DO, Kebdani T, Allaoua M, Lehmann W, Dulguerov P: Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys. 2004, 59: 1295-300.
Article
CAS
PubMed
Google Scholar
Greven KM, Williams DW, McGuirt WF, Harkness BA, D'Agostino RB, Keyes JW, Watson NE: Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck. 2001, 23: 942-6. 10.1002/hed.1136.
Article
CAS
PubMed
Google Scholar
Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Cheng AJ, Yen TC: Preoperative [18F] fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys. 2009, 74: 1054-61.
Article
PubMed
Google Scholar
Kyzas P, Evangelou E, Denaxa-Kyza D, Ioannidis JP: 18-F-Flurodeoxyglucose positron emission tomography to evaluate cervical node metastases in patietns with head and neck squamous cell carcinoma: A meta-analysis. J Natl Can Inst. 2008, 100: 712-20. 10.1093/jnci/djn125.
Article
Google Scholar
Yao M, Nguyen T, Dornfeld KJ: Prognostic Significance of FDG PET for Head and Neck Cancer Treated with IMRT. Int J Radiat Oncol Biol Phys. 2005, S1 (63): S149-S150.
Article
Google Scholar
Branstetter B, Blodgett T, Zimmer L, Snyderman CH, Johnson JT, Raman S, Meltzer CC: Head and neck malignancy: is PET/CT more accurate than PET or CT alone?. Radiology. 2005, 235: 580-586. 10.1148/radiol.2352040134.
Article
PubMed
Google Scholar
Endo K, Oriuchi N, Higuchi T, Iida Y, Hanaoka H, Miyakubo M, Ishikita T, Koyama K: PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients. Int J Clin Oncol. 2006, 4: 286-296. 10.1007/s10147-006-0595-0.
Article
Google Scholar
Schoder H, Yeung H, Gonen M, Kraus D, Larson SM: Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004, 231: 66-72. 10.1148/radiol.2311030271.
Article
Google Scholar
Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK: Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008, 26: 3582-9. 10.1200/JCO.2007.14.8841.
Article
CAS
PubMed
Google Scholar
Posner MR, Hershock Dm, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM, Haddad RI: Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007, 357: 1705-15. 10.1056/NEJMoa070956.
Article
CAS
PubMed
Google Scholar
Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL: Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007, 357: 1695-704. 10.1056/NEJMoa071028.
Article
CAS
PubMed
Google Scholar
Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefèbvre JL: Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005, 27: 843-50. 10.1002/hed.20279.
Article
PubMed
Google Scholar